S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

DRUG Bright Minds Biosciences Inc

35.41

-3.48 (-8.95%)

14 Jan 2025 - Closed

Delayed by 15 minutes

Form D - Notice of Exempt Offering of Securities

Bright Minds Biosciences (NASDAQ:DRUG)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Bright Minds Biosciences Charts.

Bright Minds Biosciences (NASDAQ:DRUG)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Bright Minds Biosciences Charts.

Bright Minds Biosciences Inc News

Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer
Tuesday 7 January 2025 (7 days ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 22 November 2024 (2 months ago) • Edgar (US Regulatory)

Bright Minds Biosciences to Present Data at the American Epilepsy Society 2024 Annual Meeting
Friday 22 November 2024 (2 months ago) • GlobeNewswire Inc.

Form D - Notice of Exempt Offering of Securities
Wednesday 20 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Wednesday 6 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Wednesday 6 November 2024 (2 months ago) • Edgar (US Regulatory)

Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement
Tuesday 5 November 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Saturday 26 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 22 October 2024 (3 months ago) • Edgar (US Regulatory)

Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data
Monday 21 October 2024 (3 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Saturday 19 October 2024 (3 months ago) • Edgar (US Regulatory)

Bright Minds Biosciences Announces US$35 Million Non-Brokered Private Placement
Friday 18 October 2024 (3 months ago) • GlobeNewswire Inc.

More Bright Minds Biosciences Inc News Articles

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions